myc Boxes, Which Are Conserved in myc Family Proteins, Are Signals for Protein Degradation via the Proteasome

REFERENCES

• Albert, T., B. Urlbauer, F. Kohlhuber, B. Hammersen, and D. Eick 1994. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt’s lymphoma cell lines. Oncogene 9: 759–763.
   PubMed Web of Science ®Google Scholar
• Alexandrova, N., J. Niklinski, V. Bliskovsky, G. A. Otterson, M. Blake, F. J. Kaye, and M. Zajac-Kaye 1995. The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. Mol. Cell. Biol. 15: 5188–5195.
   PubMed Web of Science ®Google Scholar
• Amati, B., S. Dalton, M. W. Brooks, T. D. Littlewood, G. I. Evan, and H. Land 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359: 423–426.
   PubMed Web of Science ®Google Scholar
• Amin, C., A. J. Wagner, and N. Hay 1993. Sequence-specific transcriptional activation by Myc and repression by Max. Mol. Cell. Biol. 13: 383–390.
   PubMed Web of Science ®Google Scholar
• Ariga, H., Y. Imamura, and S. M. Iguchi-Ariga 1989. DNA replication origin and transcriptional enhancer in c-myc gene share the c-myc protein binding sequences. EMBO J. 8: 4273–4279.
   PubMedGoogle Scholar
• Asker, C. E., K. P. Magnusson, S. P. Piccoli, K. Andersson, G. Klein, M. D. Cole, and K. G. Wiman 1995. Mouse and rat B-myc share amino acid sequence homology with the c-myc transcriptional activator domain and contain a B-myc specific carboxy terminal region. Oncogene 11: 1963–1969.
   PubMedGoogle Scholar
• Bachmair, A., D. Finley, and A. Varshavsky 1986. In vivo half-life of a protein is a function of its amino-terminal residue. Science 234: 179–186.
   PubMed Web of Science ®Google Scholar
• Beijersbergen, R. L., E. M. Hijmans, L. Zhu, and R. Bernards 1994. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J. 13: 4080–4086.
   PubMedGoogle Scholar
• Benvenisty, N., A. Leder, A. Kuo, and P. Leder 1992. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev. 6: 2513–2523.
   PubMedGoogle Scholar
• Bhatia, K., K. Huppi, G. Spangler, D. Siwarski, R. Iyer, and I. Magrath 1993. Point mutations in the c-Myc transactivation domain are common in Burkitt’s lymphoma and mouse plasmacytomas. Nat. Genet. 5: 56–61.
   PubMed Web of Science ®Google Scholar
• Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250: 1149–1151.
   PubMed Web of Science ®Google Scholar
• Blackwood, E. M., and R. N. Eisenman 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211–1217.
   PubMed Web of Science ®Google Scholar
• Bogyo, M., J. S. McMaster, M. Gaczynska, D. Tortorella, A. L. Goldberg, and H. Ploegh 1997. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog Hslv by a new class of inhibitors. Proc. Natl. Acad. Sci. USA 94: 6629–6634.
   PubMed Web of Science ®Google Scholar
• Bonvini, P., P. Nguyen, J. Trepel, and L. Neckers 1998. In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasome. Oncogene 16: 1131–1140.
   PubMedGoogle Scholar
• Brough, D. E., T. J. Hofmann, K. B. Ellwood, R. A. Townley, and M. D. Cole 1995. An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation. Mol. Cell. Biol. 15: 1536–1544.
   PubMedGoogle Scholar
• Christy, R. J., K. H. Kaestner, D. E. Geiman, and M. D. Lane 1991. CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc. Natl. Acad. Sci. USA 88: 2593–2597.
   PubMed Web of Science ®Google Scholar
• Church, G. M., and W. Gilbert 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81: 1991–1995.
   PubMed Web of Science ®Google Scholar
• Ciechanover, A., J. A. DiGiuseppe, B. Bercovich, A. Orian, J. D. Richter, A. L. Schwartz, and G. M. Brodeur 1991. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc. Natl. Acad. Sci. USA 88: 139–143.
   PubMed Web of Science ®Google Scholar
• Crouch, D. H., F. Fisher, W. Clark, P. S. Jayaraman, C. R. Goding, and D. A. Gillespie 1993. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity. Oncogene 8: 1849–1855.
   PubMedGoogle Scholar
• Dang, C. V., M. McGuire, M. Buckmire, and W. M. Lee 1989. Involvement of the ‘leucine zipper’ region in the oligomerization and transforming activity of human c-myc protein. Nature 337: 664–666.
   PubMed Web of Science ®Google Scholar
• Dang, C. V., H. van Dam, M. Buckmire, and W. M. Lee 1989. DNA-binding domain of human c-Myc produced in Escherichia coli. Mol. Cell. Biol. 9: 2477–2486.
   PubMedGoogle Scholar
• Eilers, M., S. Schirm, and J. M. Bishop 1991. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 10: 133–141.
   PubMed Web of Science ®Google Scholar
• Flinn, E. M. Unpublished data.
   Google Scholar
• Galaktionov, K., X. Chen, and D. Beach 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382: 511–517.
   PubMed Web of Science ®Google Scholar
• Glotzer, M., A. W. Murray, and M. W. Kirschner 1991. Cyclin is degraded by the ubiquitin pathway. Nature 349: 132–138.
   PubMed Web of Science ®Google Scholar
• Gorski, K., M. Carneiro, and U. Schibler 1986. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47: 767–776.
   PubMed Web of Science ®Google Scholar
• Grandori, C., J. Mac, F. Siebelt, D. E. Ayer, and R. N. Eisenman 1996. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15: 4344–4357.
   PubMed Web of Science ®Google Scholar
• Gu, W., K. Bhatia, I. T. Magrath, C. V. Dang, and R. Dalla-Favera 1994. Binding and suppression of the Myc transcriptional activation domain by p107. Science 264: 251–254.
   PubMedGoogle Scholar
• Gupta, S., A. Seth, and R. J. Davis 1993. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc. Natl. Acad. Sci. USA 90: 3216–3220.
   PubMed Web of Science ®Google Scholar
• Hann, S. R., and R. N. Eisenman 1984. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4: 2486–2497.
   PubMed Web of Science ®Google Scholar
• Hann, S. R., M. W. King, D. L. Bentley, C. W. Anderson, and R. N. Eisenman 1988. A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt’s lymphomas. Cell 52: 185–195.
   PubMed Web of Science ®Google Scholar
• Hateboer, G., H. T. Timmers, A. K. Rustgi, M. Billaud, L. J. van’t Veer, and R. Bernards 1993. TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. Proc. Natl. Acad. Sci. USA 90: 8489–8493.
   PubMedGoogle Scholar
• Henriksson, M., A. Bakardjiev, G. Klein, and B. Luscher 1993. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. Oncogene 8: 3199–3209.
   PubMed Web of Science ®Google Scholar
• Hochstrasser, M., and A. Varshavsky 1990. In vivo degradation of a transcriptional regulator: the yeast alpha 2 repressor. Cell 61: 697–708.
   PubMed Web of Science ®Google Scholar
• Horvath, A., and H. Riezman 1994. Rapid protein extraction from Saccharomyces cerevisiae. Yeast 10: 1305–1310.
   PubMed Web of Science ®Google Scholar
• Ito, H., Y. Fukuda, K. Murata, and A. Kimura 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153: 163–168.
   PubMed Web of Science ®Google Scholar
• Jones, E. W. 1991. Three proteolytic systems in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 266: 7963–7966.
   PubMedGoogle Scholar
• Jones, R. M., J. Branda, K. A. Johnston, M. Polymenis, M. Gadd, A. Rustgi, L. Callanan, and E. V. Schmidt 1996. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Mol. Cell. Biol. 16: 4754–4764.
   PubMed Web of Science ®Google Scholar
• Kato, G. J., J. Barrett, M. Villa-Garcia, and C. V. Dang 1990. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10: 5914–5920.
   PubMed Web of Science ®Google Scholar
• Kohl, N. E., E. Legouy, R. A. DePinho, P. D. Nisen, R. K. Smith, C. E. Gee, and F. W. Alt 1986. Human N-myc is closely related in organization and nucleotide sequence to c-myc. Nature 319: 73–77.
   PubMedGoogle Scholar
• Kornitzer, D., B. Raboy, R. G. Kulka, and G. R. Fink 1994. Regulated degradation of the transcription factor Gcn4. EMBO J. 13: 6021–6030.
   PubMedGoogle Scholar
• Kunkel, T. A., J. D. Roberts, and R. A. Zakour 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154: 367–382.
   PubMed Web of Science ®Google Scholar
• Laird-Offringa, I. A. 1992. What determines the instability of c-myc proto-oncogene mRNA? Bioessays 14: 119–124.
   PubMedGoogle Scholar
• Lech, K., K. Anderson, and R. Brent 1988. DNA-bound Fos proteins activate transcription in yeast. Cell 52: 179–184.
   PubMedGoogle Scholar
• Legouy, E., R. DePinho, K. Zimmerman, R. Collum, G. Yancopoulos, L. Mitsock, R. Kriz, and F. W. Alt 1987. Structure and expression of the murine L-myc gene. EMBO J. 6: 3359–3366.
   PubMedGoogle Scholar
• Lewis, B. C., H. Shim, Q. Li, C. S. Wu, L. A. Lee, A. Maity, and C. V. Dang 1997. Identification of putative c-myc-responsive genes: characterization of rcl, a novel growth-related gene. Mol. Cell. Biol. 17: 4967–4978.
   PubMedGoogle Scholar
• Li, L. H., C. Nerlov, G. Prendergast, D. MacGregor, and E. B. Ziff 1994. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13: 4070–4079.
   PubMedGoogle Scholar
• Luscher, B., and R. N. Eisenman 1988. c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Mol. Cell. Biol. 8: 2504–2512.
   PubMedGoogle Scholar
• Luscher, B., and R. N. Eisenman 1990. New light on Myc and Myb. I. Myc. Genes Dev. 4: 2025–2035.
   PubMed Web of Science ®Google Scholar
• Magrath, I. 1990. The pathogenesis of Burkitt’s lymphoma. Adv. Cancer Res. 55: 133–270.
   PubMedGoogle Scholar
• Marhin, W. W., S. Chen, L. M. Facchini, Fornace A. J., Jr., and L. Z. Penn 1997. Myc represses the growth arrest gene gadd45. Oncogene 14: 2825–2834.
   PubMedGoogle Scholar
• McEwan, I. J., K. Dahlman-Wright, J. Ford, and A. P. Wright 1996. Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding. Biochemistry 35: 9584–9593.
   PubMedGoogle Scholar
• Murakami, Y., S. Matsufuji, T. Kameji, S. Hayashi, K. Igarashi, T. Tamura, K. Tanaka, and A. Ichihara 1992. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360: 597–599.
   PubMed Web of Science ®Google Scholar
• Penn, L. J. Z., M. W. Brooks, E. M. Laufer, T. D. Littlewood, J. P. Morgenstern, G. I. Evan, W. M. F. Lee, and H. Land 1990. Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol. Cell. Biol. 10: 4961–4966.
   PubMedGoogle Scholar
• Philipp, A., A. Schneider, I. Vasrik, K. Finke, Y. Xiong, D. Beach, K. Alitalo, and M. Eilers 1994. Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol. 14: 4032–4043.
   PubMed Web of Science ®Google Scholar
• Pickart, C. M. 1997. Targeting of substrates to the 268 proteasome. FASEB J. 11: 1055–1066.
   PubMed Web of Science ®Google Scholar
• Pistoi, S., J. Roland, C. Babinet, and D. Morello 1996. Exon 2-mediated c-myc mRNA decay in vivo is independent of its translation. Mol. Cell. Biol. 16: 5107–5116.
   PubMedGoogle Scholar
• Prendergast, G. C., L. E. Diamond, D. Dahl, and M. D. Cole 1990. The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol. Cell. Biol. 10: 1265–1269.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C., and E. B. Ziff 1992. A new bind for Myc. Trends Genet. 8: 91–96.
   PubMedGoogle Scholar
• Pulverer, B. J., C. Fisher, K. Vousden, T. Littlewood, G. Evan, and J. R. Woodgett 1994. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 9: 59–70.
   PubMed Web of Science ®Google Scholar
• Ramsay, G., G. I. Evan, and J. M. Bishop 1984. The protein encoded by the human proto-oncogene c-myc. Proc. Natl. Acad. Sci. USA 81: 7742–7746.
   PubMed Web of Science ®Google Scholar
• Rechsteiner, M., and S. W. Rogers 1996. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21: 267–271.
   PubMed Web of Science ®Google Scholar
• Rose, M. D., F. Winston, and P. Heiter 1990. Yeast genetics: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Rosenberg-Hasson, Y., Z. Bercovich, A. Ciechanover, and C. Kahana 1989. Degradation of ornithine decarboxylase in mammalian cells is ATP dependent but ubiquitin independent. Eur. J. Biochem. 185: 469–474.
   PubMedGoogle Scholar
• Sarid, J., T. D. Halazonetis, W. Murphy, and P. Leder 1987. Evolutionarily conserved regions of the human c-myc protein can be uncoupled from transforming activity. Proc. Natl. Acad. Sci. USA 84: 170–173.
   PubMedGoogle Scholar
• Schiavi, S. C., J. G. Belasco, and M. E. Greenberg 1992. Regulation of proto-oncogene mRNA stability. Biochim. Biophys. Acta 1114: 95–106.
   PubMedGoogle Scholar
• Schmitt, M. E., T. A. Brown, and B. L. Trumpower 1990. A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res. 18: 3091–3092.
   PubMed Web of Science ®Google Scholar
• Spotts, G. D., S. V. Patel, Q. Xiao, and S. R. Hann 1997. Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol. Cell. Biol. 17: 1459–1468.
   PubMedGoogle Scholar
• Stanton, L. W., M. Schwab, and J. M. Bishop 1986. Nucleotide sequence of the human N-myc gene. Proc. Natl. Acad. Sci. USA 83: 1772–1776.
   PubMedGoogle Scholar
• Stone, J., T. de Lange, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7: 1697–1709.
   PubMed Web of Science ®Google Scholar
• Sugiyama, A., A. Kume, K. Nemoto, S. Y. Lee, Y. Asami, F. Nemoto, S. Nishimura, and Y. Kuchino 1989. Isolation and characterization of s-myc, a member of the rat myc gene family. Proc. Natl. Acad. Sci. USA 86: 9144–9148.
   PubMed Web of Science ®Google Scholar
• Svaren, J., J. Schmitz, and W. Horz 1994. The transactivation domain of Pho4 is required for nucleosome disruption at the PHO5 promoter. EMBO J. 13: 4856–4862.
   PubMedGoogle Scholar
• Treier, M., L. M. Staszewski, and D. Bohmann 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78: 787–798.
   PubMed Web of Science ®Google Scholar
• Visintin, R., S. Prinz, and A. Amon 1997. CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science 278: 460–463.
   PubMed Web of Science ®Google Scholar
• Wagner, A. J., C. Meyers, L. A. Laimins, and N. Hay 1993. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4: 879–883.
   PubMedGoogle Scholar
• Yeilding, N. M., and W. M. Lee 1997. Coding elements in exons 2 and 3 target c-myc mRNA downregulation during myogenic differentiation. Mol. Cell. Biol. 17: 2698–2707.
   PubMedGoogle Scholar
• Yeilding, N. M., M. T. Rehman, and W. M. Lee 1996. Identification of sequences in c-myc mRNA that regulate its steady-state levels. Mol. Cell. Biol. 16: 3511–3522.
   PubMedGoogle Scholar